Abstract

Objective: Serum from SSc patients was analyzed centrally to determine ANA patterns and extractable nuclear antigens (ENAs) between lcSSc and dcSSc and associations with organ involvement. Methods: 1145 SSc patients had ANA and ENA analyzed by indirect immunofluorescence on HEp-2 substrate at a screening serum dilution of 1/160. Most ENA antibodies [Sm. U1-RNP, Ro52, SS-A/Ro60, topoisomeraseI (Topo1), SS-B/La, chromatin, ribosomal P and Jo1] were measured by laser bead immunoassay; and RNA polymerase III (RNAP) by ELISA. Results: ANA was positive in 95% (same in lcSSc, and dcSSc). Centromere pattern was present in 34%, speckled 22%, nucleolar 18%, homogeneous and speckled (H&S) 16%, multiple nuclear dots 6%. Anti-centromere Ab (ACA) occurred in 46% of lcSSc and 11% of dcSSc (P = 0.0001). ENAs that differed between lcSSc and dcSSc subsets were Topo1 (OR 2.4, P = 0.0001) and RNAP (OR 5.6, P 0.0001) more common in dcSSc. Overall, 15% had positive Topo1; usually with a H&S pattern (67%); Topo1 was associated with ILD on CXR (OR 2.3; 95% CI 1.5 - 3.5) and HRCT (OR 3.8; 95% CI 1.8 - 8.2). RNAP occurred in 18.5% (35.4% in dcSSc vs. 8.9% in lcSSc). Scleroderma renal crisis (SRC) was 13 times more likely if RNAP positive; P = 0.0001. ACA was only weakly associated with sPAP > 50 mmHg (OR 1.8; 95%CI 1.1 - 3.0). Conclusion: ANA homogeneous pattern alone is rare in SSc; ACA was significantly more common in lcSSc. Many ENAs are equal in lcSSc and dcSSc except RNAP and Topo1. RNAP has the highest OR of SRC. Topo1 is less strongly associated with ILD. Abstract word count: 249, Body word count 1246, Figures 2, Tables 2. Key Messages: 1) 95% of SSc has a positive ANA and ANA patterns in SSc include centromere, nucleolar, and homogeneous and speckled together; 2) Most ENAs are equal in both dcSSc and lcSSc except anti RNA polymerase III and topoisomerase I; 3) RNA polymerase III has the highest association (odds ratio) with scleroderma renal crisis, topoisomerase I is associated with interstitial lung disease; whereas anticentromere was not associated with elevated pulmonary arterial pressures on echocardiogram.

Highlights

  • Systemic Sclerosis (SSc) is an autoimmune disorder cau-sing various clinical manifestations related to skin fibrosis and internal organ dysfunction

  • anti centromere antibody (ACA) was positive in a third of patients; 46% of Limited cutaneous systemic sclerosis (lcSSc) patients and 11% of diffuse cutaneous systemic sclerosis (dcSSc) (P = 0.0001)

  • This study showed TopoI positivity in 16.7% overall; a higher rate was found in dcSSc versus lcSSc

Read more

Summary

Introduction

Systemic Sclerosis (SSc) is an autoimmune disorder cau-. Sing various clinical manifestations related to skin fibrosis and internal organ dysfunction. Limited cutaneous systemic sclerosis (lcSSc) primarily affects the skin of the fingers and hands, while diffuse cutaneous systemic sclerosis (dcSSc) is known to affect skin tissue and organs more extensively [1]. The presence of autoantibodies can be associated with disease pathology and progression. Autoantibodies in Systemic Sclerosis and Associations with Organ Involvement: Results the Canadian Scleroderma Research Group (CSRG). Dies (ANA) are found in over 90% of patients with SSc [2]. The type of ANA is related to reactions against specific components of the cell, and is associated with certain clinical manifestations of disease. Types include anti centromere antibody (ACA), anti-topoisomeraseI (anti-topo I) and anti RNA polymerase III (RNAP)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call